
Findings from a retrospective study lend support to the idea that even in men with a Gleason 7 (3+4) biopsy score, prostate cancer may sometimes act like low-risk disease.

Findings from a retrospective study lend support to the idea that even in men with a Gleason 7 (3+4) biopsy score, prostate cancer may sometimes act like low-risk disease.

The test could be a step closer to personalized risk-based prostate cancer diagnostic programs, study authors say.

Researchers say they’ve uncovered a wide variation in costs to treat low-risk prostate cancer.

The authors evaluated cumulative incidence of re-operation after various surgical procedures for urinary incontinence within 5 years.

A recent systematic review found that the total incidence of serious complications and/or sling failure with respect to incontinence was 15.3%.

With 87% of all adults using the Internet and 70% of all millennials searching for a doctor online, it’s become essential for every health care professional to cultivate an online presence, and social media is the quickest route to establishing it.

Movember is a global movement that leverages the power of the mustache to promote men's health. Hear from Brian Stork, MD as he shares insight into what Movember means for him and what you need to know.

“The best way to avoid overtreatment is to avoid overdiagnosis. MRI allows you to do that," says Mark Emberton, MD.

In this case study, a man in his fifth decade of life complained of right side testicular swelling that had persisted for 2 weeks. He reported no pain.

A novel artificial urinary sphincter is safe and effective in men with stress urinary incontinence, according to data from a small study presented at the International Continence Society annual meeting in Montreal.

My story begins last fall when I went through the process of signing up for health insurance through my practice. As I trust insurance companies about as much as I trust the government, I took what I thought were reasonable precautions.

The implementation of ICD-10 has all of us reevaluating diagnosis coding.

With the widespread acceptance of robot-assisted surgery for reconstructive procedures such as radical prostatectomy and partial nephrectomy, the next frontier for urologic robotic-assisted surgery appears to be in the female pelvis.

A new challenge to Obamacare has even its most ardent supporters nervous.

In this installment in a series on privacy and information security concerns, I will discuss steps you can take to safeguard your patients’ personal information.

A smartphone app for pelvic floor muscle training has valuable potential as a portal to patient care and education and for facilitating clinical outcomes research, according to its developers from the University of California, San Francisco.

Novel ultrasound-based techniques for propelling and breaking kidney stones could soon join ESWL and URS in the urologist’s treatment armamentarium. In this interview, Michael Bailey, PhD, discusses how these technologies work, what they’re capable of, and where they are in development.

Urologists lament how prior authorization and EHRs take them away from their patients.

Proposed cuts by the Centers for Medicare & Medicaid Services in Medicare payments for radiation oncology services would force an estimated 30% of community-based radiation therapy centers to close their doors, according to a statement sent to CMS by the American Society of Radiation Oncology.

A robot-assisted abdominal approach to pelvic organ prolapse repair has a favorable safety profile and is associated with durable anatomic outcomes, findings of a retrospective chart review indicate.

Other products highlighted in this slideshow include a trial system for incontinence therapy, a compact catheter, a wearable digital technology solution for continence care assessment and management, and laser fiber and sheath system.

As we approach the end of the year, the tax moves that you make-or don’t make-can have a significant impact on your 2015 tax return.

Over the last 5 years, we have developed a comprehensive, multispecialty, hospital-based men's health center, and we believe that the following five elements are the keys to its success.

A prostate cancer vaccine and an infertility diagnostic tool are among the other pipeline products discussed in this round-up.

The pressure is on for many U.S. urologists to take a hard look at whether to practice privately or as part of a hospital system. We asked two urologists to weigh in about the lessons they learned in transitioning from one practice type to another.

The time has arrived for all urologists to become involved in the business side of their practice.

OnabotulinumtoxinA (Botox) appears to offer long-term benefits in patients with neurogenic detrusor overactivity, recent study results indicate.

Intravesical onabotulinumtoxinA (Botox) reduces bladder pain in patients with interstitial cystitis/bladder pain syndrome (IC/BPS), two separate studies show.

Symptomatic urinary tract infection is unlikely after office-based cystoscopy, although recent antibiotic exposure or hospitalization raise infection risk, according to a recent study.